Editorial Advisory Board Members


Jack Barrette

Founder and CEO,
WEGO Health

Christine Coyne

VP, Specialty Pharmacuticals,
BTG

Deborah Dick-Rath

President,
Epic Proportions

Fabio Gratton

Co-founder and Innovation Catalyst 
Sonic Health

Shwen Gwee

VP/group director of social strategy,
Digital Health

John Kamp

Executive Director,
Coalition for Healthcare Communication

Camille Lee

SVP, Diabetes Marketing,
Novo Nordisk

Mike Luby

Founder, President and CEO,
BioPharma Alliance

Cynthia North

Customer Marketing Director,
Bayer HealthCare Pharmaceuticals

Jennifer Rinaldo

Senior Product Director,
Forest Laboratories


Joe Shields

Leader, Digital Marketing,
AstraZeneca

Sheila Thorne

President/CEO, Multicultural
Healthcare Marketing Group

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.